Zobrazeno 1 - 10
of 73
pro vyhledávání: '"H. M. VRIESENDORP"'
Autor:
G. I. Shapiro, Sheila Prachand, Leo I. Gordon, Merrill S. Kies, H. M. Vriesendorp, Steve Rosen
Publikováno v:
International journal of oncology. 2(6)
Peripheral blood or bone marrow cells of 15 patients with chronic lymphocytic leukemia (CLL) were separated on an albumin density gradient. In 5 of 5 CLL patients, the distribution of malignant B lymphocytes was similar across the gradient when blood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::012ffdac322a8ee28511095bc6210a71
https://pubmed.ncbi.nlm.nih.gov/21573656
https://pubmed.ncbi.nlm.nih.gov/21573656
Autor:
J, Lai, S M, Quadri, P E, Borchardt, L, Harris, R, Wucher, E, Askew, L, Schweichel, H M, Vriesendorp
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5
The objective was to identify pharmacokinetic parameters predictive for tumor response and normal tissue side effects after i.v. administered radiolabeled rabbit antihuman ferritin IgG. Twenty-eight patients with recurrent Hodgkin's disease received
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::60044e4bc90d782723187caa4f002ebd
https://pubmed.ncbi.nlm.nih.gov/10541380
https://pubmed.ncbi.nlm.nih.gov/10541380
Autor:
H M, Vriesendorp, S M, Quadri, C T, Wyllie, J, Lai, P E, Borchardt, L, Harris, R, Wucher, E, Askew, L, Schweichler
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5
The objective of this study was to determine the therapeutic ratio of fractionated radiolabeled immunoglobulin therapy (RIT) for patients with recurrent Hodgkin's disease. Ninety patients with recurrent Hodgkin's disease received 2 mg of yttrium-90-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dca5033d29ab4dffd8dbb5b1b743442a
https://pubmed.ncbi.nlm.nih.gov/10541381
https://pubmed.ncbi.nlm.nih.gov/10541381
Autor:
S M, Quadri, H M, Vriesendorp
Publikováno v:
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR). 42(4)
Radiolabeled monoclonal antibodies reactive with tumor-associated antigens can selectively deliver cytotoxic or diagnostic isotopes to malignant cells in vivo. To achieve maximum retention of radiolabel in tumor and a more rapid clearance of radioiso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::41e463fdcb0562193920d488656c7351
https://pubmed.ncbi.nlm.nih.gov/9973840
https://pubmed.ncbi.nlm.nih.gov/9973840
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 39(3)
Most patients with ovarian cancer have disease in the peritoneal cavity. Treatment of this region is inadequate because recurrences are frequent. Increased radiation doses to tumor and, hence, greater tumor control may be possible with intraperitonea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::98c71c357ffb7eb77af490ac11503ce9
https://pubmed.ncbi.nlm.nih.gov/9529295
https://pubmed.ncbi.nlm.nih.gov/9529295
Publikováno v:
Cancer. 80
Indium-111 labeled antiferritin targets 95% of all Hodgkin's disease lesions with a diameter of 1 cm or more. Subsequent treatment with yttrium-90 labeled antiferritin secures a high response rate in patients with recurrent Hodgkin's disease.A total
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d11da29bd43f047d8d793deff66ba349
https://pubmed.ncbi.nlm.nih.gov/9406730
https://pubmed.ncbi.nlm.nih.gov/9406730
Autor:
F J, Vriesendorp, S M, Quadri, R E, Flynn, M R, Malone, D M, Cromeens, L C, Stephens, H M, Vriesendorp
Publikováno v:
Cancer. 80
Unlabeled murine monoclonal anti-GD2 immunoglobulin (Ig)G (14G2a) reactive with nervous system diganglioside and neuroblastoma, melanoma, and small cell lung carcinoma produces tumor regression. However, serious acute abdominal pain, paresthesia, hyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d59d9dcb9cad82adcbb51ef330a01731
https://pubmed.ncbi.nlm.nih.gov/9406719
https://pubmed.ncbi.nlm.nih.gov/9406719
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 37(9)
Radiolabeled monoclonal antibodies are utilized increasingly for the diagnosis and treatment of human cancer. Tumor targeting of radiolabeled human monoclonal IgM improves with compartmental administration and might be useful for the diagnosis or tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a89d182649ca5ace929feac562140a5e
https://pubmed.ncbi.nlm.nih.gov/8790216
https://pubmed.ncbi.nlm.nih.gov/8790216
Publikováno v:
Experimental hematology. 24(10)
Radiolabeled immunoglobulin therapy (RIT) is a new cancer treatment that is more selective than its predecessors. Its dose-limiting normal tissue side effect is bone marrow toxicity, and hematopoietic stem cell damage appears to be its most significa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5f313462a51d090fa79813c53167d43e
https://pubmed.ncbi.nlm.nih.gov/8765492
https://pubmed.ncbi.nlm.nih.gov/8765492
Publikováno v:
Cancer research. 55
An IgM lambda human tumor cell-reactive monoclonal antibody was developed that reacts with cells of ovarian cancer, colorectal cancer, breast cancer, and certain other malignancies. The monoclonal antibody AC6C3-2B12, which was obtained from a recent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f08ce57413699aa096e7fd01a41cf1f2
https://pubmed.ncbi.nlm.nih.gov/7493338
https://pubmed.ncbi.nlm.nih.gov/7493338